NCT00421226View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Healthy
Interventions
DRUG

ACZ885

Trial Locations (1)

Unknown

Novartis Investigative site, Tokyo

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY